Navigation Links
New angel capital centered on GenTel agreement with big pharma

Madison, Wis. - GenTel BioSciences, a privately-held biotechnology company, has completed what it calls a critical round of financing activity by raising an additional $500,000 to pursue a new partnership with a large pharmaceutical company.

Alex Vodenlich, president and CEO of GenTel, said the identity of the pharma company would not be anno......

Full article >>> gov/Act255">Act 255, the state's investment tax credit program, and Wisconsin Investment Partners, a Madison-based angel investment network that emphasizes life-science investments.

"They [GenTel] have had good marketplace acceptance and nice sales growth, albeit for a young company," said Dick Leazer, a princi......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 02/20/07


Related biology technology :

1. Investor warns of angel-venture funding gap
2. Breaking down Wisconsins angel capital numbers
3. Research explains why women lack equal access to angel capital
4. Capital-raising term sheets for angels and venture capitalists
5. National angel investment grew 11 percent in `06
6. BioSystem Development secures angel funding
7. New Silicon Pastures director envisions more home cooking for Wisconsin angels
8. Milwaukee angel network invests in St. Louis company
9. Small Tree receives additional angel funding
10. Burke would like to double Act 255 angel tax credits
11. Midwest plays small role in VC investment, angel groups to the rescue
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/1/2017)... WA (PRWEB) , ... March 01, 2017 , ... ... research into the physiology of aging into clinical applications, announces the formation of ... proprietary oral-transmucosal dosage form of resveratrol, the drug which has been discussed in ...
(Date:2/28/2017)... Linda, Ca (PRWEB) , ... February 28, 2017 , ... ... molecular interactions. SPR is an optical phenomenon that is sensitive to changes in the ... resonance condition is affected by changes in refractive index occurring up to 300 nm ...
(Date:2/28/2017)... , Feb. 28, 2017  Phosphorus, a ... today the formation of the Phosphorus Scientific Advisory ... experts chosen to advise the company on the ... multi-site research initiatives. Please visit http://phosphorus.com/about-us/ ... initiatives. "We,ve gathered some of the ...
(Date:2/28/2017)... -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing ... diseases, asthma and allergic diseases and cancer, today ... full year ended December 31, 2016 and provided ... clinical highlights. "During 2016, we made ... starting five clinical trials across our XmAb portfolio.  ...
Breaking Biology Technology:
(Date:2/28/2017)... , February 28, 2017 News solutions ... ... Amsterdam from 14 to 16 March, Materna will ... and show how seamless travel is a real benefit for passengers. ... added biometrics to their passenger touch point solutions to take passengers ...
(Date:2/22/2017)... Feb. 22, 2017 With the biometrics ... Research identifies four technologies that innovative and agile ... significant share in the changing competitive landscape: multifactor ... authentication.   "Companies can no longer ... security," says Dimitrios Pavlakis , Industry Analyst ...
(Date:2/13/2017)...  RSA Conference -- RSA, a Dell Technologies business, ... enhance fraud detection and investigation across digital environments ... & Risk Intelligence Suite. The new platform is ... from internal and external sources as well as ... from targeted cybercrime attacks. "Fraudsters are ...
Breaking Biology News(10 mins):